TOP STORIES

• REGULATORY Importance of Non-ICER Factors in Cost-Effectiveness Assessment Starting to Resonate with Chuikyo Reps
  February 7, 2019

• REGULATORY Kymriah Up for MHLW Panel Review on Feb. 20 as Japan’s 1st CAR-T Therapy
  February 6, 2019

• ORGANIZATION PhRMA Takes Issue with Japan Govt’s Overreliance on ICER, Proposes Point-Based Appraisal Framework
  February 5, 2019

• BUSINESS Sawai and 7 Other Generic Makers Seeking Lyrica Patent Invalidity
  February 4, 2019

• BUSINESS Oncolys Plans to Begin Japan PII Study of Oncolytic Virus in 2nd Half of 2019
  February 1, 2019

• REGULATORY Faulty Wage Data Might Have Affected Drug Pricing as Labor Stats Used for Cost-Based Method
  January 31, 2019

• TRENDS Drug Formulary Initiatives Moving Beyond Hospitals, Generic Makers Prepping for Regional Lists
  January 30, 2019

• BUSINESS Nippon Express to Set Up 4 Distribution Centers for Full-Scale Drug Logistics Biz, Aims for 15 Billion Yen Annual Sales
  January 29, 2019

• BUSINESS Xofluza Enjoys Commanding Lead with 47% Share in October-December, MHLW Data Show
  January 28, 2019

• BUSINESS Takeda’s Specialty Business Unit Boots Up with Entyvio Detailing
  January 25, 2019

• REGULATORY MHLW Unveils Outline of Cost-Effective Assessment Scheme: Chuikyo
  January 24, 2019

• BUSINESS Mitsubishi Tanabe Eyes US as 1st Launch Market, Zeroes in on Immunology/CNS: Chief
  January 22, 2019

• BUSINESS Shionogi Facing Xofluza Supply Crunch as Flu Season Gets into Full Swing
  January 21, 2019

• BUSINESS Mitsubishi Tanabe Staffers Tapping New Support System to Balance Work and Infertility, Medical Treatment
  January 18, 2019

• REGULATORY PMDA to Specify Target Overall Review Period for Regenerative Medicine Products: FY2019-2023 Plan
  January 17, 2019

• REGULATORY MHLW Won’t Necessarily Push March Announcement of New Drug Prices: Bureau Head
  January 16, 2019

• BUSINESS Japan Pharma Market Sags 2% in April-December as Pricing Overhaul Weighs: Encise
  January 15, 2019

• REGULATORY PMDA to Raise Fees and Expand Workforce to Boost Review and Safety Measures, GMP Inspection
  January 15, 2019

• COMMENTARY 2019 Likely to Herald Burst of “Regenerative Medicine” Approvals
  January 11, 2019

• REGULATORY MHLW to Revise Biosimilar Guidelines to Increase Efficiency in Development, Review; Final Draft Expected in FY2019
  January 10, 2019

ページ

• « 先頭
• ‹ Prev
• …
• 140
• 141
• 142
• 143
• 144
• 145
• 146
• 147
• 148
• …
• Next ›
• 最終 »